BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3326187)

  • 21. Loss of heparan sulfate proteoglycan from glomerular basement membrane of nephrotic rats.
    Mynderse LA; Hassell JR; Kleinman HK; Martin GR; Martinez-Hernandez A
    Lab Invest; 1983 Mar; 48(3):292-302. PubMed ID: 6219248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemically induced polycystic kidney disease.
    Crocker JF; Blecher SR; Safe SH
    Prog Clin Biol Res; 1983; 140():281-96. PubMed ID: 6369340
    [No Abstract]   [Full Text] [Related]  

  • 23. Functional changes in polycystic kidney disease are tubulo-interstitial in origin.
    Carone FA
    Semin Nephrol; 1988 Mar; 8(1):89-93. PubMed ID: 3363249
    [No Abstract]   [Full Text] [Related]  

  • 24. Polycystic kidney disease induced by corticoids. A quantitative and qualitative analysis of cell populations in the tubular cysts.
    Ojeda JL; Ros MA; García-Porrero JA
    Nephron; 1986; 42(3):240-8. PubMed ID: 3945365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pathogenesis of polycystic kidney disease.
    Carone FA; Bacallao R; Kanwar YS
    Histol Histopathol; 1995 Jan; 10(1):213-21. PubMed ID: 7756739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrastructural tubular basement membrane lesions in adult polycystic kidney disease.
    Katz SK; Hakki A; Miller AS; Finkelstein SD
    Ann Clin Lab Sci; 1989; 19(5):352-9. PubMed ID: 2802515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathophysiology of renal tubular cyst formation in murine models of polycystic kidney disease.
    Sweeney WE; Avner ED
    Contrib Nephrol; 1992; 97():23-34. PubMed ID: 1633715
    [No Abstract]   [Full Text] [Related]  

  • 28. Polycystic kidney disease in the CBA/N immunodeficient mouse.
    Rahilly MA; Samuel K; Ansell JD; Micklem HS; Fleming S
    J Pathol; 1992 Nov; 168(3):335-42. PubMed ID: 1469511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acidic glycosaminoglycans and laminin-1 in renal corpuscles of mutant blebs (my) and control mice.
    Center EM; Emery KE
    Histol Histopathol; 1997 Oct; 12(4):901-7. PubMed ID: 9302549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal basement membrane components.
    Miner JH
    Kidney Int; 1999 Dec; 56(6):2016-24. PubMed ID: 10594777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basement membrane antigens in renal polycystic disease.
    Carone FA; Makino H; Kanwar YS
    Am J Pathol; 1988 Mar; 130(3):466-71. PubMed ID: 3279792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polycystic kidney syndrome in New Zealand White rabbits resembling human polycystic kidney disease.
    Maurer KJ; Marini RP; Fox JG; Rogers AB
    Kidney Int; 2004 Feb; 65(2):482-9. PubMed ID: 14717918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early embryonic renal tubules of wild-type and polycystic kidney disease kidneys respond to cAMP stimulation with cystic fibrosis transmembrane conductance regulator/Na(+),K(+),2Cl(-) Co-transporter-dependent cystic dilation.
    Magenheimer BS; St John PL; Isom KS; Abrahamson DR; De Lisle RC; Wallace DP; Maser RL; Grantham JJ; Calvet JP
    J Am Soc Nephrol; 2006 Dec; 17(12):3424-37. PubMed ID: 17108316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sirolimus ameliorates the enhanced expression of metalloproteinases in a rat model of autosomal dominant polycystic kidney disease.
    Berthier CC; Wahl PR; Le Hir M; Marti HP; Wagner U; Rehrauer H; Wüthrich RP; Serra AL
    Nephrol Dial Transplant; 2008 Mar; 23(3):880-9. PubMed ID: 18042615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal tubular hyperplasia, polycystic disease, and glomerulosclerosis in transgenic mice overexpressing hepatocyte growth factor/scatter factor.
    Takayama H; LaRochelle WJ; Sabnis SG; Otsuka T; Merlino G
    Lab Invest; 1997 Aug; 77(2):131-8. PubMed ID: 9274855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphology of cystic renal lesions. Lectin and immuno-histochemical study.
    Kovács J; Zilahy M; Gomba S
    Acta Chir Hung; 1997; 36(1-4):176-8. PubMed ID: 9408336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polycystic renal disease: a new experimental model.
    Perey DY; Herdman RC; Good RA
    Science; 1967 Oct; 158(3800):494-6. PubMed ID: 6048105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The spatial and temporal expression of the alpha 2 beta 1 integrin and its ligands, collagen I, collagen IV, and laminin, suggest important roles in mouse mammary morphogenesis.
    Keely PJ; Wu JE; Santoro SA
    Differentiation; 1995 Jul; 59(1):1-13. PubMed ID: 7589890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A hypomorphic mutation in the mouse laminin alpha5 gene causes polycystic kidney disease.
    Shannon MB; Patton BL; Harvey SJ; Miner JH
    J Am Soc Nephrol; 2006 Jul; 17(7):1913-22. PubMed ID: 16790509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Basement membrane degradative enzymes as possible markers of tumor metastasis.
    Nakajima M; Welch DR; Irimura T; Nicolson GL
    Prog Clin Biol Res; 1986; 212():113-22. PubMed ID: 2940601
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.